246 related articles for article (PubMed ID: 31864071)
1. Midbrain hyperechogenicity, hyposmia, mild parkinsonian signs and risk for incident Parkinson's disease over 10 years: A prospective population-based study.
Mahlknecht P; Stockner H; Marini K; Gasperi A; Djamshidian A; Willeit P; Kiechl S; Willeit J; Rungger G; Poewe W; Seppi K
Parkinsonism Relat Disord; 2020 Jan; 70():51-54. PubMed ID: 31864071
[TBL] [Abstract][Full Text] [Related]
2. Predictors for mild parkinsonian signs: a prospective population-based study.
Mahlknecht P; Kiechl S; Stockner H; Willeit J; Gasperi A; Poewe W; Seppi K
Parkinsonism Relat Disord; 2015 Mar; 21(3):321-4. PubMed ID: 25585991
[TBL] [Abstract][Full Text] [Related]
3. Value of combined midbrain sonography, olfactory and motor function assessment in the differential diagnosis of early Parkinson's disease.
Busse K; Heilmann R; Kleinschmidt S; Abu-Mugheisib M; Höppner J; Wunderlich C; Gemende I; Kaulitz L; Wolters A; Benecke R; Walter U
J Neurol Neurosurg Psychiatry; 2012 Apr; 83(4):441-7. PubMed ID: 22362921
[TBL] [Abstract][Full Text] [Related]
4. A population-based study on combined markers for early Parkinson's disease.
Tunc S; Graf J; Tadic V; Brüggemann N; Schmidt A; Al-Khaled M; Wolff S; Vollstedt EJ; Lorwin A; Hampf J; Piskol L; Klein C; Hagenah J; Kasten M
Mov Disord; 2015 Apr; 30(4):531-7. PubMed ID: 25546094
[TBL] [Abstract][Full Text] [Related]
5. Substantia nigra hyperechogenicity in essential tremor and Parkinson's disease: a longitudinal study.
Cardaioli G; Ripandelli F; Paolini Paoletti F; Nigro P; Simoni S; Brahimi E; Romoli M; Filidei M; Eusebi P; Calabresi P; Tambasco N
Eur J Neurol; 2019 Nov; 26(11):1370-1376. PubMed ID: 31094036
[TBL] [Abstract][Full Text] [Related]
6. Pre-motor signs of PD are related to SN hyperechogenicity assessed by TCS in an elderly population.
Liepelt I; Behnke S; Schweitzer K; Wolf B; Godau J; Wollenweber F; Dillmann U; Gaenslen A; Di Santo A; Maetzler W; Berg D
Neurobiol Aging; 2011 Sep; 32(9):1599-606. PubMed ID: 19897277
[TBL] [Abstract][Full Text] [Related]
7. Diagnostic value of combined assessment of olfaction and sustantia nigra hyperechogenicity for Parkinson's disease.
López Hernández N; García Escrivá A; Shalabi Benavent M
Neurologia; 2015 Oct; 30(8):496-501. PubMed ID: 24839905
[TBL] [Abstract][Full Text] [Related]
8. Risk factors and prodromal markers and the development of Parkinson's disease.
Lerche S; Seppi K; Behnke S; Liepelt-Scarfone I; Godau J; Mahlknecht P; Gaenslen A; Brockmann K; Srulijes K; Huber H; Wurster I; Stockner H; Kiechl S; Willeit J; Gasperi A; Fassbender K; Poewe W; Berg D
J Neurol; 2014 Jan; 261(1):180-7. PubMed ID: 24190794
[TBL] [Abstract][Full Text] [Related]
9. Enlarged hyperechogenic substantia nigra as a risk marker for Parkinson's disease.
Berg D; Behnke S; Seppi K; Godau J; Lerche S; Mahlknecht P; Liepelt-Scarfone I; Pausch C; Schneider N; Gaenslen A; Brockmann K; Srulijes K; Huber H; Wurster I; Stockner H; Kiechl S; Willeit J; Gasperi A; Fassbender K; Gasser T; Poewe W
Mov Disord; 2013 Feb; 28(2):216-9. PubMed ID: 23115051
[TBL] [Abstract][Full Text] [Related]
10. Substantia nigra hyperechogenicity is a risk marker of Parkinson's disease: yes.
Berg D
J Neural Transm (Vienna); 2011 Apr; 118(4):613-9. PubMed ID: 21207077
[TBL] [Abstract][Full Text] [Related]
11. Frequency and profile of Parkinson's disease prodromi in patients with malignant melanoma.
Walter U; Heilmann E; Voss J; Riedel K; Zhivov A; Schäd SG; Gross GE; Benecke R; Trcka J
J Neurol Neurosurg Psychiatry; 2016 Mar; 87(3):302-10. PubMed ID: 25817520
[TBL] [Abstract][Full Text] [Related]
12. Enlarged substantia nigra hyperechogenicity and risk for Parkinson disease: a 37-month 3-center study of 1847 older persons.
Berg D; Seppi K; Behnke S; Liepelt I; Schweitzer K; Stockner H; Wollenweber F; Gaenslen A; Mahlknecht P; Spiegel J; Godau J; Huber H; Srulijes K; Kiechl S; Bentele M; Gasperi A; Schubert T; Hiry T; Probst M; Schneider V; Klenk J; Sawires M; Willeit J; Maetzler W; Fassbender K; Gasser T; Poewe W
Arch Neurol; 2011 Jul; 68(7):932-7. PubMed ID: 21747034
[TBL] [Abstract][Full Text] [Related]
13. Reasons for mild parkinsonian signs - which constellation may indicate neurodegeneration?
Lerche S; Brockmann K; Wurster I; Gaenslen A; Roeben B; Holz D; Eschweiler GW; Maetzler W; Berg D
Parkinsonism Relat Disord; 2015 Feb; 21(2):126-30. PubMed ID: 25511329
[TBL] [Abstract][Full Text] [Related]
14. Substantia nigra hyperechogenicity and Parkinson's disease risk in patients with essential tremor.
Sprenger FS; Wurster I; Seppi K; Stockner H; Scherfler C; Sojer M; Schmidauer C; Berg D; Poewe W
Mov Disord; 2016 Apr; 31(4):579-83. PubMed ID: 26893155
[TBL] [Abstract][Full Text] [Related]
15. Prodromal Parkinson's disease as defined per MDS research criteria in the general elderly community.
Mahlknecht P; Gasperi A; Willeit P; Kiechl S; Stockner H; Willeit J; Rungger G; Sawires M; Nocker M; Rastner V; Mair KJ; Hotter A; Poewe W; Seppi K
Mov Disord; 2016 Sep; 31(9):1405-8. PubMed ID: 27273736
[TBL] [Abstract][Full Text] [Related]
16. Prediction of Parkinson's disease subsequent to severe depression: a ten-year follow-up study.
Walter U; Heilmann R; Kaulitz L; Just T; Krause BJ; Benecke R; Höppner J
J Neural Transm (Vienna); 2015 Jun; 122(6):789-97. PubMed ID: 25217967
[TBL] [Abstract][Full Text] [Related]
17. Substantia nigra hyperechogenicity as a marker for Parkinson's disease: a population-based study.
Mahlknecht P; Seppi K; Stockner H; Nocker M; Scherfler C; Kiechl S; Willeit J; Schmidauer C; Gasperi A; Rungger G; Poewe W
Neurodegener Dis; 2013; 12(4):212-8. PubMed ID: 23689066
[TBL] [Abstract][Full Text] [Related]
18. Substantia nigra echogenicity is associated with serum ferritin, gender and iron-related genes in Parkinson's disease.
Li K; Ge YL; Gu CC; Zhang JR; Jin H; Li J; Cheng XY; Yang YP; Wang F; Zhang YC; Chen J; Mao CJ; Liu CF
Sci Rep; 2020 May; 10(1):8660. PubMed ID: 32457446
[TBL] [Abstract][Full Text] [Related]
19. Five-year follow-up of substantia nigra echogenicity in idiopathic REM sleep behavior disorder.
Iranzo A; Stockner H; Serradell M; Seppi K; Valldeoriola F; Frauscher B; Molinuevo JL; Vilaseca I; Mitterling T; Gaig C; Vilas D; Santamaria J; Högl B; Tolosa E; Poewe W
Mov Disord; 2014 Dec; 29(14):1774-80. PubMed ID: 25384461
[TBL] [Abstract][Full Text] [Related]
20. Performance of the Movement Disorders Society criteria for prodromal Parkinson's disease: A population-based 10-year study.
Mahlknecht P; Gasperi A; Djamshidian A; Kiechl S; Stockner H; Willeit P; Willeit J; Rungger G; Poewe W; Seppi K
Mov Disord; 2018 Mar; 33(3):405-413. PubMed ID: 29436728
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
